These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31411112)

  • 1. Structure and dynamics of inactive and active MARK4: conformational switching through the activation process.
    Ahrari S; Mogharrab N; Navapour L
    J Biomol Struct Dyn; 2020 May; 38(8):2468-2481. PubMed ID: 31411112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
    Trinczek B; Brajenovic M; Ebneth A; Drewes G
    J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
    Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.
    Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C
    Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interconversion of inactive to active conformation of MARK2: Insights from molecular modeling and molecular dynamics simulation.
    Ahrari S; Mogharrab N; Navapour L
    Arch Biochem Biophys; 2017 Sep; 630():66-80. PubMed ID: 28711359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
    Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
    Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARK4 protein can explore the active-like conformations in its non-phosphorylated state.
    Ahrari S; Khosravi F; Osouli A; Sakhteman A; Nematollahi A; Ghasemi Y; Savardashtaki A
    Sci Rep; 2019 Sep; 9(1):12967. PubMed ID: 31506531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule affinity-regulating kinase 4: structure, function, and regulation.
    Naz F; Anjum F; Islam A; Ahmad F; Hassan MI
    Cell Biochem Biophys; 2013 Nov; 67(2):485-99. PubMed ID: 23471664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
    Ashraf GM; DasGupta D; Alam MZ; Baeesa SS; Alghamdi BS; Anwar F; Alqurashi TMA; Sharaf SE; Al Abdulmonem W; Alyousef MA; Alhumaydhi FA; Shamsi A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
    Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
    Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro.
    Naz F; Islam A; Ahmad F; Hassan MI
    Mol Cell Biochem; 2015 Dec; 410(1-2):223-8. PubMed ID: 26346160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of glioblastoma multiforme associated mutations on the structure and function of MAP/microtubule affinity regulating kinase 4.
    Naqvi AAT; Jairajpuri DS; Hussain A; Hasan GM; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2021 Mar; 39(5):1781-1794. PubMed ID: 32141394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
    Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
    J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
    Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
    Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights.
    Anwar S; Choudhury A; Hussain A; AlAjmi MF; Hassan MI; Islam A
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130090. PubMed ID: 38342269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase (GSK) 3beta directly phosphorylates Serine 212 in the regulatory loop and inhibits microtubule affinity-regulating kinase (MARK) 2.
    Timm T; Balusamy K; Li X; Biernat J; Mandelkow E; Mandelkow EM
    J Biol Chem; 2008 Jul; 283(27):18873-82. PubMed ID: 18424437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
    Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
    Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
    Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.